Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%

Wed, 28th Jul 2021 10:58

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Hutchmed (China) Ltd, up 9.0% at 585.08 pence, 12-month range 337.00p-656.00p. Alongside AstraZeneca PLC, the Hong Kong-based pharmaceutical company kicks off a phase 2 trial of Orpathys in some cancer patients. A first patient was dosed on Tuesday. The trial will probe the effectiveness of Orpathys in sufferers of advanced or metastatic MET amplified gastric cancer, - cancer formed in the lining of the stomach - or adenocarcinoma of the gastroesophageal junction, cancer of the oesophagus which connects a body's mouth to the stomach. Metastatic cancer refers to when the disease spreads to other parts of the body.

----------

Staffline PLC, up 9.1% at 63.50p, 12-month range 23.24p-82.38p. The recruitment and training firm rises in a positive read-across from mid-cap peer FDM Group Holdings PLC. FDM's pretax profit for the six months to June 30 falls 3.3% to GBP20.5 million from GBP21.2 million. The London-based firm posted revenue of GBP131.3 million, down 6.5% from GBP140.5 million. However, recruitment and training levels ramped up significantly in the first half to meet growing client demand, FDM says. Its stock was 3.0%.

----------

Empire Metals Ltd, up 7.8% at 2.59 p, 12-month range 1.70p-5.73p. The resource exploration and development company says the third phase of reverse circulation drilling of Eclipse gold project in Australia shows "encouraging results". Drilling confirms the existence of "additional mineralised zones".

----------

AIM - LOSERS

----------

Tricorn Group PLC, down 25% at 3.77p, 12-month range 3.16p-9.00p. The Worcestershire-based tube parts manufacturer hits this 12-month low on Wednesday as it warns that, while it is working within its lending facilities, it may soon need to operate outside of them as cost pressures ramp up. Tricorn notes global supply chain disruption as well as pressure on operating costs, margins and working capital. What's more, some overdue debts from customers are still outstanding. "Whilst the group's principal lending bank is expected to remain supportive, certain restrictions on these facilities are being imposed," Tricorn cautions, adding that these curbs will be eased in the event of an injection of funds.

----------

Total Produce PLC, down 16% at 177.92p, 12-month range 85.75p-235.00p. The fresh produce firm says the initial public offering price for joint venture company Dole PLC has been cut to between USD16 and USD17 per share from USD20 to USD23 previously. Total Produce says its shareholders will own just over 57% of Dole post-IPO, down from just shy of 62%.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.